Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats-Reference-Cited by-同舟云学术

Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats

Published:2024-09-11 Issue:1 Volume:16 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Duan Haoru,Song Shanshan,Li Rui,Hu Suqin,Zhuang Shuting,liu Shaoyang,Li Xiaolu,Gao Wei

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13098-024-01432-7.pdf

Reference76 articles.

1. Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications-what the non-specialist needs to know. Diabetes Obes Metab. 2022;24(Suppl 2):3–14.

2. Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet (London England). 2022;400(10365):1803–20.

3. Xie J, Huang H, Liu Z, Li Y, Yu C, Xu L, et al. The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive mendelian randomization study. Hepatology (Baltimore MD). 2023;77(3):949–64.

4. Butt AS, Hamid S, Haider Z, Sharif F, Salih M, Awan S, et al. Nonalcoholic fatty liver diseases among recently diagnosed patients with diabetes Mellitus and Risk factors. Euroasian J hepato-gastroenterology. 2019;9(1):9–13.

5. Santos RD, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis. 2019;282:110–20.